## **Core Concept**
Hereditary spherocytosis (HS) is a genetic disorder characterized by the production of red blood cells (RBCs) that are sphere-shaped rather than the normal biconcave disk shape. This abnormal shape results from mutations in genes encoding proteins of the RBC membrane skeleton, leading to reduced RBC deformability, premature destruction, and variable degrees of anemia.

## **Why the Correct Answer is Right**
The management of hereditary spherocytosis often involves supportive care, with a focus on alleviating symptoms and improving quality of life. Splenectomy is a definitive treatment that can significantly improve anemia, reduce reticulocytosis, and decrease the risk of gallstones. The current practice guideline typically recommends splenectomy for patients with moderate to severe HS, as it addresses the primary issue of hemolysis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, guidelines support splenectomy for certain cases.
- **Option B:** Similarly, not provided, but treatments usually aim at managing symptoms and preventing complications.
- **Option C:** Without specifics, it's hard to address, but generally, management strategies focus on supportive care and sometimes surgical intervention.
- **Option D:** Given that the correct answer is ". ", we infer that option D likely contradicts current practices for managing HS.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while splenectomy can significantly improve the hematologic parameters in patients with hereditary spherocytosis, it does not eliminate the risk of gallstones, which are common in these patients due to chronic hemolysis. Therefore, patients with HS, even after splenectomy, should be monitored for signs of gallstones.

## **Correct Answer: D.**